Shares of Canadian materials firm 5N Plus surged after securing an $18.1 million U.S. government grant to expand germanium recycling in Utah and announcing a 25% capacity increase for space-grade solar cells at its German subsidiary, AZUR SPACE, by 2026.
As Match Group's Q4 2025 earnings call nears, heightened options activity and third-party app data point to a pivotal moment for the dating app giant. Analysts are scrutinizing Tinder's user engagement trends, which could either validate a turnaround narrative or exacerbate concerns over slowing growth and mounting debt.
PayPal Holdings Inc. announced the immediate departure of CEO Alex Chriss and a sobering earnings forecast, triggering a sharp sell-off in its shares as the payments giant grapples with intensifying competition and a slowdown in its core business.
A significant 58% of The Smarter Web Company Plc (LON:SWC) is owned by retail investors, giving them substantial influence over corporate decisions, while institutional holdings stand at a modest 13%, according to a recent ownership analysis.
Shares of animal health leader Zoetis Inc. (ZTS) traded lower this week following a subdued financial outlook for 2026. The stock's underperformance was highlighted in Diamond Hill Capital's latest investor letter, which contrasted the company's challenges against a broader market rally fueled by AI optimism.
Diamond Hill Capital's Large Cap Fund added medical device maker Cooper Companies (COO) to its portfolio in Q4 2025, positioning for long-term growth in the resilient contact lens and women's health sectors despite recent stock weakness.
Citi Research has initiated coverage on Sanofi with a Neutral rating and an €85 price target, citing pipeline setbacks and a lack of near-term catalysts. The analysis comes as the French pharma giant reports positive Phase 3 results for its eczema drug amlitelimab.
Industrial electronics giant AMETEK (NYSE:AME) delivered a strong top-line performance for the fourth quarter of 2025, surpassing revenue expectations with 13.4% year-over-year growth. However, a closer look reveals pressure on operating margins, painting a nuanced picture for the diversified manufacturer.
As Elon Musk's xAI prepares to merge with SpaceX, the hiring of a cryptocurrency quantitative expert points to ambitions beyond Earth-bound AI, aiming to integrate blockchain data and decentralized finance protocols into a future space-based data network.
Elon Musk's newly merged AI venture, xAI, is actively seeking cryptocurrency experts to train its models on digital asset markets. The move follows the blockbuster union with SpaceX and points to a strategic push into AI-driven financial analysis.
Tesla's planned $20 billion capital expenditure signals a fundamental shift, betting its future on AI-driven robotaxis and autonomy. This high-risk, high-reward strategy redefines the company and poses a critical question for investors.
Pzena Investment Management's Focused Value Strategy underperformed in Q4 2025, citing a challenging environment dominated by mega-cap AI stocks. Healthcare giant Baxter International was singled out as a significant drag on the portfolio's performance during the period.
PayPal Holdings Inc. reported fourth-quarter revenue that fell short of Wall Street expectations, sending its stock plunging nearly 15% and raising questions about the digital payments pioneer's growth trajectory in a competitive market.
As the TSX rides a wave of robust Q4 earnings, savvy investors are looking past the blue chips. We delve into three lesser-known Canadian companies—spanning energy, aerospace, and energy services—that combine solid fundamentals with strategic moves to capitalize on current economic tailwinds.
Despite a robust 45% surge in earnings per share, Lonza Group AG (VTX:LONN) shareholders have seen their investment decline by 11% over the past year, starkly underperforming the broader Swiss market. This divergence underscores how investor sentiment and future expectations can overshadow even solid current financial performance.
GE HealthCare secures dual US and European regulatory approvals for its new Allia Moveo imaging system, designed to enhance patient comfort and streamline clinical workflows in minimally invasive procedures.
A wave of panic selling has engulfed the software sector, with even giants like Microsoft not spared. Investors are fleeing on fears that artificial intelligence will erode pricing power, competitive advantages, and long-term growth, creating what traders are calling a 'SaaSpocalypse'.
CNBC's Jim Cramer expresses apprehension ahead of Advanced Micro Devices' quarterly report, suggesting even strong results may not satisfy a market exhibiting a new, unforgiving pattern toward chip stocks.
CNBC's Jim Cramer has spotlighted Merck & Co. as a strategic holding, praising the pharmaceutical giant's acquisition-driven strategy to build a more balanced portfolio ahead of its blockbuster drug's patent cliff.
As the artificial intelligence boom enters a new phase of enterprise deployment, investors are looking beyond pure software to the foundational hardware layer. We analyze three key companies powering the AI revolution and why their roles may offer a compelling, lower-risk investment thesis this February.
